Allergy Therapeutics plc (AIM: AGY)

Allergy Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	13.52	14.85	20.52	40.27	36.96	27.44
Cash & Short-Term Investments	13.52	14.85	20.52	40.27	36.96	27.44
Cash Growth	-11.02%	-27.64%	-49.06%	8.96%	34.70%	76.66%
Accounts Receivable	9.93	2.37	2.69	2.96	3.49	4.49
Other Receivables	-	2.69	3.21	1.66	2.16	4
Receivables	9.93	5.06	5.91	4.62	5.65	8.49
Inventory	11.89	11.59	11.41	10.84	10.13	9.41
Prepaid Expenses	-	2.03	4.56	1.6	2.42	1.28
Other Current Assets	-	-	-	0.53	-	-
Total Current Assets	35.35	33.53	42.39	57.86	55.17	46.63
Property, Plant & Equipment	23.39	23.24	20.19	19.72	20.42	11.48
Goodwill	3.36	3.35	3.35	3.34	3.47	3.43
Other Intangible Assets	1.63	1.79	1.69	1.41	1.27	1.41
Other Long-Term Assets	5.35	4.87	5.33	5.76	5.9	5.55
Total Assets	69.08	66.77	72.95	88.09	86.23	68.5
Accounts Payable	20.09	4.09	4.28	2.9	2.22	4.14
Accrued Expenses	-	12.49	11.34	13.55	12.86	11.46
Current Portion of Long-Term Debt	0.64	0.65	0.95	0.96	0.83	0.69
Current Portion of Leases	1.12	1.16	1.32	0.79	1.44	-
Other Current Liabilities	3.43	0.18	0.16	0.03	0.89	0.56
Total Current Liabilities	25.27	18.57	18.05	18.23	18.23	16.86
Long-Term Debt	0.95	26.44	1.5	2.45	2.93	1.74
Long-Term Leases	7.15	7.75	6.76	6.97	6.99	-
Long-Term Deferred Tax Liabilities	0.46	0.45	0.41	0.41	0.47	0.32
Other Long-Term Liabilities	0.1	3.58	0.14	0.21	0.3	0.27
Total Liabilities	42.62	64.7	35.18	39.55	42.44	30.94
Common Stock	4.78	0.68	0.64	0.64	0.64	0.64
Additional Paid-In Capital	154.67	119.03	112.58	112.58	112.58	112.58
Retained Earnings	-174.69	-161.87	-118.54	-107.4	-112.96	-119.18
Comprensive Income & Other	41.7	44.23	43.09	42.72	43.53	43.52
Shareholders' Equity	26.46	2.07	37.77	48.54	43.78	37.56
Total Liabilities & Equity	69.08	66.77	72.95	88.09	86.23	68.5
Total Debt	9.85	35.99	10.53	11.17	12.18	2.44
Net Cash (Debt)	3.67	-21.14	9.99	29.1	24.78	25
Net Cash Growth	-32.28%	-	-65.69%	17.42%	-0.88%	100.43%
Net Cash Per Share	0.00	-0.03	0.02	0.04	0.04	0.04
Filing Date Shares Outstanding	4,766	679.1	644.1	641.77	637.29	636.17
Total Common Shares Outstanding	4,766	679.1	644.1	641.77	637.29	636.17
Working Capital	10.08	14.96	24.34	39.63	36.94	29.77
Book Value Per Share	0.01	0.00	0.06	0.08	0.07	0.06
Tangible Book Value	21.47	-3.07	32.73	43.78	39.05	32.72
Tangible Book Value Per Share	0.00	-0.00	0.05	0.07	0.06	0.05
Land	-	3.05	3.08	3.09	11.87	3.05
Machinery	-	33.68	29.66	27.35	26.97	23.87

Source: S&P Capital IQ. Standard template. Financial Sources.